tiprankstipranks
Reviva Reports Full Year 2023 Financial Results and Recent Business Highlights
PremiumPress ReleasesReviva Reports Full Year 2023 Financial Results and Recent Business Highlights
21d ago
Reviva Pharmaceuticals announces anticipated milestones, events
PremiumThe Fly
Reviva Pharmaceuticals announces anticipated milestones, events
21d ago
Reviva Pharmaceuticals reports 2023 EPS ($1.65), consensus ($1.63)
PremiumThe Fly
Reviva Pharmaceuticals reports 2023 EPS ($1.65), consensus ($1.63)
21d ago
Reviva Pharmaceuticals to host KOL event to discuss data on brilaroxazine
PremiumThe FlyReviva Pharmaceuticals to host KOL event to discuss data on brilaroxazine
3M ago
Reviva Pharmaceuticals files $200M mixed securities shelf
PremiumThe Fly
Reviva Pharmaceuticals files $200M mixed securities shelf
3M ago
Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
PremiumPress Releases
Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
3M ago
Reviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
PremiumPress ReleasesReviva to Participate in the Zacks Small-Cap Research Life Sciences Investor Forum
5M ago
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
6M ago
Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
PremiumPress Releases
Reviva Announces Closing of $30 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100